| 000 | 01262 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513032155.0 | ||
| 264 | 0 | _c19951025 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a0090-1229 | ||
| 024 | 7 |
_a10.1016/0090-1229(95)90144-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Poll, T | |
| 245 | 0 | 0 |
_aInterleukin 6 during active visceral leishmaniasis and after treatment. _h[electronic resource] |
| 260 |
_bClinical immunology and immunopathology _cOct 1995 |
||
| 300 |
_a111-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntimony Sodium Gluconate _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aLeishmaniasis, Visceral _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aZijlstra, E E | |
| 700 | 1 | _aMevissen, M | |
| 773 | 0 |
_tClinical immunology and immunopathology _gvol. 77 _gno. 1 _gp. 111-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-1229(95)90144-2 _zAvailable from publisher's website |
| 999 |
_c7553931 _d7553931 |
||